METTL3 Promotes OSCC Progression by Down-Regulating WEE1 in a m6A-YTHDF2-Dependent Manner

被引:1
|
作者
Su, Yongxu [1 ]
Hu, Yanjia [2 ]
Qu, Binbin [1 ]
Lei, Rongchang [1 ]
Guo, Ge [1 ]
机构
[1] Changsha Stomatol Hosp, Dept Oral & Maxilofacial Sugery, Changsha 410004, Hunan, Peoples R China
[2] Cent South Univ, Dept Oral & Maxilofacial Sugery, Xiangya Stomatol Hosp, Changsha 410000, Hunan, Peoples R China
关键词
OSCC; WEE1; METTL3; YTHDF2; m6A; CARCINOMA; TUMORIGENESIS; METHYLATION; CANCER;
D O I
10.1007/s12033-024-01165-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oral squamous cell carcinoma (OSCC) is a common and highly lethal epithelial cancer. This study aimed to confirm the role of METTL3 in promoting OSCC and investigate its specific underlying mechanisms. Expression of the METTL3, YTH domain-containing family 2 (YTHDF2), and WEE1 were examined in normal oral epithelial cells and OSCC cells. Cell functions were examined after overexpressing WEE1 in OSCC cells. MeRIP-qPCR analysis was used to detect WEE1 m6A levels in HOK, SCC25, and CAL27 cells. WEE1 and its m6A levels were evaluated in OSCC cells by knocking down METTL3/YTHDF2, assessing the interaction between METTL3/YTHDF2 and WEE1. The impact of METTL3 and YTHDF2 downregulation on WEE1 mRNA stability was also investigated. The tumor weight and volume in a nude mouse model of OSCC after overexpression of WEE1 and YTHDF2 were measured. Expression of Ki-67 and WEE1 in OSCC tissue was detected using immunohistochemistry. Compared to normal oral epithelial cells, METTL3 and YTHDF2 were upregulated in OSCC cells, while WEE1 was downregulated, and there was a negative correlation between WEE1 and METTL3/YTHDF2 expression. WEE1 overexpression inhibited proliferation, invasion, and migration while promoting apoptosis in OSCC cells. METTL3 and YTHDF2 bound to WEE1 mRNA. METTL3/YTHDF2 knockdown increased WEE1 levels and WEE1 mRNA stability. METTL3 inhibition reduced WEE1 m6A levels. Inhibition of METTL3 weakened the interaction between YTHDF2 and WEE1 mRNA. In vivo, overexpression of WEE1 suppressed OSCC development, which was reversed by overexpression of YTHDF2. METTL3 facilitates the progression of OSCC through m6A-YTHDF2-dependent downregulation of WEE1.Graphic AbstractMETTL3 promotes OSCC progression by enhancing WEE1 mRNA degradation in a m6A-YTHDF2-dependent manner. METTL3 enhances the binding of cytoplasmic YTHDF2 to m6A modification sites on WEE1 mRNA, thereby promoting WEE1 mRNA degradation and facilitating OSCC progression.
引用
收藏
页码:1867 / 1879
页数:13
相关论文
共 50 条
  • [31] The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
    Shi, Yue
    Dou, Yanliang
    Zhang, Jianye
    Qi, Jie
    Xin, Zijuan
    Zhang, Mingxin
    Xiao, Yu
    Ci, Weimin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [32] RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming
    Zheng, Longbin
    Chen, Xiang
    Yin, Quanwen
    Gu, Jiaming
    Chen, Jiajing
    Chen, Minghong
    Zhang, Yunjia
    Dong, Mengdie
    Jiang, Hong
    Yin, Ning
    Chen, Hongshan
    Li, Xuesong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 635 : 120 - 127
  • [33] METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A methylation-modified miR-320a
    Gao, Ding
    Shi, Jian
    Lu, Siyu
    Li, Junyi
    Lv, Kehan
    Xu, Yongqing
    Song, Muguo
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01):
  • [34] METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA
    Du, Qiu-Ying
    Huo, Fu-Chun
    Du, Wen-Qi
    Sun, Xiao-Lin
    Jiang, Xin
    Zhang, Lan-Sheng
    Pei, Dong-Sheng
    ONCOGENE, 2022, 41 (39) : 4420 - 4432
  • [35] METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression
    Guo, Yu-qing
    Wang, Qiang
    Wang, Jun-guo
    Gu, Ya-jun
    Song, Pan-pan
    Wang, Shou-yu
    Qian, Xiao-yun
    Gao, Xia
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [36] WTAP promotes laryngeal carcinoma cell progression by posttranscriptional activation of CTHRC1 in an m6A-YTHDF1-dependent way
    Feng, Lan
    Wang, Qingdong
    Zang, Rongjia
    Zhang, Meijia
    CYTOTECHNOLOGY, 2024, 76 (06) : 709 - 720
  • [37] m6A methyltransferase METTL3 promotes oral squamous cell carcinoma progression through enhancement of IGF2BP2-mediated SLC7A11 mRNA stability
    Xu, Le
    Li, Qingdang
    Wang, Yifei
    Wang, Lin
    Guo, Yuxing
    Yang, Rong
    Zhao, Na
    Ge, Na
    Wang, Yixiang
    Guo, Chuanbin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (11): : 5282 - +
  • [38] METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6
    Li, Yongqing
    Zhang, Dantong
    Gao, Yinan
    Wang, Peijun
    Wang, Zejun
    Zhang, Bingyang
    Liu, Junjun
    Ye, Diwen
    Ma, Wanshan
    Lu, Sumei
    NUTRITION & METABOLISM, 2023, 20 (01)
  • [39] RETRACTED: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner (Retracted Article)
    Liu, Xiangxiang
    Qin, Jian
    Gao, Tianyi
    Li, Chenmeng
    He, Bangshun
    Pan, Bei
    Xu, Xueni
    Chen, Xiaoxiang
    Zeng, Kaixuan
    Xu, Mu
    Zhu, Chengbin
    Pan, Yuqin
    Sun, Huiling
    Sun, Li
    Xu, Tao
    Wang, Shukui
    MOLECULAR THERAPY NUCLEIC ACIDS, 2020, 22 : 750 - 765
  • [40] SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner
    Zhang, Shouji
    Zhao, Shulin
    Qi, Yanhua
    Li, Boyan
    Wang, Huizhi
    Pan, Ziwen
    Xue, Hao
    Jin, Chuandi
    Qiu, Wei
    Chen, Zihang
    Guo, Qindong
    Fan, Yang
    Xu, Jianye
    Gao, Zijie
    Wang, Shaobo
    Guo, Xing
    Deng, Lin
    Ni, Shilei
    Xue, Fuzhong
    Wang, Jian
    Zhao, Rongrong
    Li, Gang
    MOLECULAR THERAPY NUCLEIC ACIDS, 2022, 27 : 699 - 717